Trials / Not Yet Recruiting
Not Yet RecruitingNCT06752460
Evaluation of the EF192B Protection Versus No Treatment
Randomized, Open Clinical Study to Evaluate the Protective Potential of EF192B Versus No Treatment
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Eurofarma Laboratorios S.A. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study was designed with the objective of evaluating the protection potential provided by the experimental product EF192B by evaluating its barrier formation capacity. Once its ability to form a barrier is confirmed, EF192B ability to protect against small skin injuries, such as small cuts, bruises, blisters and cracks is confirmed. The barrier formation also guarantees protection against the formation of calluses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EF192B | EF192B will be applied after the tape strriping procedure and will be reapplied after 12 hours. |
Timeline
- Start date
- 2025-08-31
- Primary completion
- 2025-10-31
- Completion
- 2025-10-31
- First posted
- 2024-12-30
- Last updated
- 2024-12-30
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT06752460. Inclusion in this directory is not an endorsement.